跳至主要内容
临床试验/NL-OMON52284
NL-OMON52284招募中不适用

A clinical imaging Study of the changes in [18F]F-AraG uptake following radiotherapy in Non-small cell lung cancer. - SHARP

Vrije Universiteit Medisch Centrum0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Histologically confirmed NSCLC, melanoma, esophageal, or breast cancer
  • Ongoing immunotherapy using an anti-PD-(L)1 agent
  • Planned to be treated with high dose (24Gy) radiotherapy per clinical
  • Be willing and able to provide written informed consent for the trial.
  • Have a performance status of 0-2 on the ECOG Performance Scale
  • Be above 18 years of age on day of signing informed consent.

排除标准

  • Subjects with a condition requiring systemic treatment with either
  • corticosteroids (>10 mg daily prednisone equivalent) or other immunosuppressive
  • medications within 14 days of day 0. Inhaled or topical steroids, and adrenal
  • replacement steroid >10 mg daily prednisone equivalent, are permitted in the
  • absence of active autoimmune disease.
  • Psychiatric or substance abuse disorders that would interfere with
  • cooperation with the requirements of the trial.
  • Patient is pregnant or breastfeeding, or expecting to conceive within the
  • projected duration of the trial, starting with the screening visit through 12
  • weeks after the last administration of [18F]F-AraG.

研究者

相似试验